Search research articles
Contact Us
Filters
Showing results (101-110 of 196) with videos related to
Page
of 20
Sort By:
Therapeutic Drug Monitoring
|
May 20, 2020
Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants
Joshua C Euteneuer, Tomoyuki Mizuno, Tsuyoshi Fukuda, et al.
Journal of Clinical Pharmacology
|
April 27, 2010
Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients
Tsuyoshi Fukuda, Jens Goebel, Håvard Thøgersen, et al.
Clinical Therapeutics
|
September 11, 2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders
Michael G Aman, Alexander A Vinks, Bart Remmerie, et al.
Inflammatory Bowel Diseases
|
July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease
Laura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Journal of Clinical Pharmacology
|
May 17, 2017
Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents
Sally Selim, Robert Riesenberg, James Cassella, et al.
Clinical Pharmacokinetics
|
September 18, 2017
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation
Kana Mizuno, Min Dong, Tsuyoshi Fukuda, et al.
Clinical Pharmacokinetics
|
February 24, 2024
A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
Alina Sadaf, Min Dong, Amanda Pfeiffer, et al.
Pharmacogenomics
|
July 18, 2013
OCT1 genetic variants influence the pharmacokinetics of morphine in children
Tsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.
Journal of Opioid Management
|
September 4, 2012
Morphine clearance in children: does race or genetics matter?
Senthilkumar Sadhasivam, Elke H J Krekels, Vidya Chidambaran, et al.
Pediatric Nephrology (Berlin, Germany)
|
August 16, 2024
Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults
Kathryn Pavia, Sonya Tang Girdwood, Kelli Paice, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 196) with videos related to
Sort By:
Page
of 20
Therapeutic Drug Monitoring
|
May 20, 2020
Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants
Joshua C Euteneuer, Tomoyuki Mizuno, Tsuyoshi Fukuda, et al.
Journal of Clinical Pharmacology
|
April 27, 2010
Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients
Tsuyoshi Fukuda, Jens Goebel, Håvard Thøgersen, et al.
Clinical Therapeutics
|
September 11, 2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders
Michael G Aman, Alexander A Vinks, Bart Remmerie, et al.
Inflammatory Bowel Diseases
|
July 10, 2019
Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease
Laura E Bauman, Ye Xiong, Tomoyuki Mizuno, et al.
Journal of Clinical Pharmacology
|
May 17, 2017
Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents
Sally Selim, Robert Riesenberg, James Cassella, et al.
Clinical Pharmacokinetics
|
September 18, 2017
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation
Kana Mizuno, Min Dong, Tsuyoshi Fukuda, et al.
Clinical Pharmacokinetics
|
February 24, 2024
A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
Alina Sadaf, Min Dong, Amanda Pfeiffer, et al.
Pharmacogenomics
|
July 18, 2013
OCT1 genetic variants influence the pharmacokinetics of morphine in children
Tsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.
Journal of Opioid Management
|
September 4, 2012
Morphine clearance in children: does race or genetics matter?
Senthilkumar Sadhasivam, Elke H J Krekels, Vidya Chidambaran, et al.
Pediatric Nephrology (Berlin, Germany)
|
August 16, 2024
Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults
Kathryn Pavia, Sonya Tang Girdwood, Kelli Paice, et al.
Page
of 20